Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-08

Clinical Trial Update: AMH, Glucose Intolerance and Metabolic Syndrome in PCOS

View source ↗

Summary

A clinical trial is evaluating anti-Müllerian hormone (AMH) in relation to glucose intolerance and metabolic syndrome in Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chulalongkorn University | Conditions: Polycystic Ovary Syndrome | Status: UNKNOWN